TFX vs. STE, PODD, BAX, HOLX, GMED, MASI, ITGR, IART, ATRC, and ATEC
Should you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Masimo (MASI), Integer (ITGR), Integra LifeSciences (IART), AtriCure (ATRC), and Alphatec (ATEC). These companies are all part of the "health care equipment" industry.
Teleflex vs.
STERIS (NYSE:STE) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.
STERIS has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.
94.7% of STERIS shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 1.1% of STERIS shares are owned by insiders. Comparatively, 1.4% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
STERIS has a net margin of 8.66% compared to Teleflex's net margin of 7.85%. Teleflex's return on equity of 14.19% beat STERIS's return on equity.
Teleflex received 188 more outperform votes than STERIS when rated by MarketBeat users. However, 59.19% of users gave STERIS an outperform vote while only 58.64% of users gave Teleflex an outperform vote.
STERIS has higher revenue and earnings than Teleflex. STERIS is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.
In the previous week, STERIS had 4 more articles in the media than Teleflex. MarketBeat recorded 20 mentions for STERIS and 16 mentions for Teleflex. STERIS's average media sentiment score of 1.43 beat Teleflex's score of 0.81 indicating that STERIS is being referred to more favorably in the media.
STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 1.0%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. STERIS pays out 48.4% of its earnings in the form of a dividend. Teleflex pays out 95.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. STERIS has increased its dividend for 20 consecutive years. STERIS is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
STERIS currently has a consensus target price of $258.75, indicating a potential upside of 16.78%. Teleflex has a consensus target price of $182.63, indicating a potential upside of 31.05%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than STERIS.
Summary
STERIS beats Teleflex on 15 of the 21 factors compared between the two stocks.
Get Teleflex News Delivered to You Automatically
Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Teleflex Competitors List
Related Companies and Tools
This page (NYSE:TFX) was last updated on 3/25/2025 by MarketBeat.com Staff